DYAI
Dyadic International IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$27.66M
P/E Ratio
—
EPS
$-0.21
Beta
1.17
52W High
$1.35
52W Low
$0.66
50-Day MA
$0.80
200-Day MA
$0.91
Dividend Yield
—
Profit Margin
-191.50%
Forward P/E
15.82
PEG Ratio
0.00
About Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces and sells enzymes and other proteins in the United States. The company is headquartered in Jupiter, Florida.
Fundamentals
| Revenue (TTM) | $3.81M |
| Gross Profit (TTM) | 993,690 |
| EBITDA | — |
| Operating Margin | -172.10% |
| Return on Equity | -2827.00% |
| Return on Assets | -56.20% |
| Revenue/Share (TTM) | $0.11 |
| Book Value | $-0.01 |
| Price-to-Book | 21.01 |
| Price-to-Sales (TTM) | 7.27 |
| EV/Revenue | 16.21 |
| EV/EBITDA | -2.93 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 182.30% |
| Shares Outstanding | $36.44M |
| Float | $27.37M |
| % Insiders | 25.53% |
| % Institutions | 14.96% |
Historical Volatility
HV 10-Day
46.18%
HV 20-Day
50.95%
HV 30-Day
46.96%
HV 60-Day
81.84%
HV Rank
12.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026